GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVNEE) » Definitions » E10

Novartis AG (XSWX:NOVNEE) E10 : CHF5.30 (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Dec. 2024 was CHF1.257. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF5.30 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Novartis AG's average E10 Growth Rate was 2.70% per year. During the past 3 years, the average E10 Growth Rate was 3.80% per year. During the past 5 years, the average E10 Growth Rate was 5.80% per year. During the past 10 years, the average E10 Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novartis AG was 8.70% per year. The lowest was -3.40% per year. And the median was 2.00% per year.

As of today (2025-03-15), Novartis AG's current stock price is CHF96.68. Novartis AG's E10 for the quarter that ended in Dec. 2024 was CHF5.30. Novartis AG's Shiller PE Ratio of today is 18.24.

During the past 13 years, the highest Shiller PE Ratio of Novartis AG was 21.68. The lowest was 12.78. And the median was 17.21.


Novartis AG E10 Historical Data

The historical data trend for Novartis AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG E10 Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 5.03 5.13 5.15 5.30

Novartis AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.15 5.22 5.30 5.29 5.30

Competitive Comparison of Novartis AG's E10

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.



Novartis AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novartis AG's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.257/107.1281*107.1281
=1.257

Current CPI (Dec. 2024) = 107.1281.

Novartis AG Quarterly Data

per share eps CPI Adj_EPS
201503 5.213 100.339 5.566
201506 0.699 100.464 0.745
201509 0.749 99.785 0.804
201512 0.438 99.386 0.472
201603 0.824 99.475 0.887
201606 0.727 100.088 0.778
201609 0.788 99.604 0.848
201612 0.408 99.380 0.440
201703 0.701 100.040 0.751
201706 0.804 100.285 0.859
201709 0.847 100.254 0.905
201712 0.829 100.213 0.886
201803 0.815 100.836 0.866
201806 3.277 101.435 3.461
201809 0.668 101.246 0.707
201812 0.506 100.906 0.537
201903 0.760 101.571 0.802
201906 2.875 102.044 3.018
201909 0.882 101.396 0.932
201912 0.481 101.063 0.510
202003 0.911 101.048 0.966
202006 0.771 100.743 0.820
202009 0.769 100.585 0.819
202012 0.817 100.241 0.873
202103 0.846 100.800 0.899
202106 1.162 101.352 1.228
202109 1.126 101.533 1.188
202112 6.668 101.776 7.019
202203 0.920 103.205 0.955
202206 0.747 104.783 0.764
202209 0.701 104.835 0.716
202212 0.633 104.666 0.648
202303 1.000 106.245 1.008
202306 0.999 106.576 1.004
202309 0.765 106.570 0.769
202312 3.511 106.461 3.533
202403 1.164 107.355 1.162
202406 1.421 107.991 1.410
202409 1.330 107.468 1.326
202412 1.257 107.128 1.257

Add all the adjusted EPS together and divide 10 will get our e10.


Novartis AG  (XSWX:NOVNEE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=96.68/5.30
=18.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Novartis AG was 21.68. The lowest was 12.78. And the median was 17.21.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novartis AG E10 Related Terms

Thank you for viewing the detailed overview of Novartis AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines